XTL Biopharmaceuticals plans IPO on LSE

XTL Biopharmaceuticals (Rehovot, Israel) said it plans to raise 25 million-30 million ($39.7 million-$47.6 million) in an IPO, with a listing on LSE (see BioCentury, the Bernstein Report on BioBusine...